Ovid Therapeutics Stock (NASDAQ: OVID) stock price, news, charts, stock research, profile.
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Other companies in Ovid Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR) and Inovio Pharmaceuticals (NASDAQ:INO).
Ovid Therapeutics has a consensus price target of $4.74.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $1.01 last updated December 23, 2024 at 6:10 AM EST.
There are no upcoming dividends for Ovid Therapeutics.
Ovid Therapeutics’s Q4 earnings are confirmed for Friday, March 7, 2025.
There is no upcoming split for Ovid Therapeutics.
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.